APA aipamena

Bienemann, A., Killick-Cole, C., Singleton, W., Arshad, A., Marcella, W., Neil, B., & Steven, G. (2017). TRTH-18. COMBINED TOPOTECAN AND CARBOPLATIN THERAPY FOR DIPG SUPPRESSES CELL GROWTH IN VITRO AND IS WELL TOLERATED WHEN DELIVERED BY CONVECTION ENHANCED DELIVERY IN VIVO. Neuro Oncol.

Chicago Style aipamena

Bienemann, Alison, Clare Killick-Cole, William Singleton, Azeem Arshad, Wyatt Marcella, Barua Neil, and Gill Steven. "TRTH-18. COMBINED TOPOTECAN AND CARBOPLATIN THERAPY FOR DIPG SUPPRESSES CELL GROWTH IN VITRO AND IS WELL TOLERATED WHEN DELIVERED BY CONVECTION ENHANCED DELIVERY IN VIVO." Neuro Oncol 2017.

MLA aipamena

Bienemann, Alison, et al. "TRTH-18. COMBINED TOPOTECAN AND CARBOPLATIN THERAPY FOR DIPG SUPPRESSES CELL GROWTH IN VITRO AND IS WELL TOLERATED WHEN DELIVERED BY CONVECTION ENHANCED DELIVERY IN VIVO." Neuro Oncol 2017.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.